Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danica Chiu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Molecular Cancer Therapeutics|May 28, 2021
Targeting Solid Tumors Using CD3 Bispecific AntibodiesAlison Crawford, Danica Chiu
Frontiers in Aging Neuroscience|January 23, 2015
Complex regulation of γ-secretase: from obligatory to modulatory subunitsNatalya Gertsik, Danica Chiu, Yue-Ming Li
Molecular Psychiatry|June 28, 2022
Hypoxia Inducible Factor-1α binds and activates γ-secretase for Aβ production under hypoxia and cerebral hypoperfusionCourtney Alexander, Thomas Li, Yorito Hattori, et al.
Cell Reports|August 19, 2014
Nontranscriptional role of Hif-1α in activation of γ-secretase and notch signaling in breast cancerJennifer C Villa, Danica Chiu, Alissa H Brandes, et al.
Cancer Immunology Research|March 19, 2020
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB CostimulationDanica Chiu, Richard Tavaré, Lauric Haber, et al.
Science Translational Medicine|June 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancerAlison Crawford, Lauric Haber, Marcus P Kelly, et al.
Scientific Reports|July 14, 2021
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuningLauric Haber, Kara Olson, Marcus P Kelly, et al.
Science Translational Medicine|January 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodiesDimitris Skokos, Janelle C Waite, Lauric Haber, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|May 28, 2021
Targeting Solid Tumors Using CD3 Bispecific AntibodiesAlison Crawford, Danica Chiu
Frontiers in Aging Neuroscience|January 23, 2015
Complex regulation of γ-secretase: from obligatory to modulatory subunitsNatalya Gertsik, Danica Chiu, Yue-Ming Li
Molecular Psychiatry|June 28, 2022
Hypoxia Inducible Factor-1α binds and activates γ-secretase for Aβ production under hypoxia and cerebral hypoperfusionCourtney Alexander, Thomas Li, Yorito Hattori, et al.
Cell Reports|August 19, 2014
Nontranscriptional role of Hif-1α in activation of γ-secretase and notch signaling in breast cancerJennifer C Villa, Danica Chiu, Alissa H Brandes, et al.
Cancer Immunology Research|March 19, 2020
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB CostimulationDanica Chiu, Richard Tavaré, Lauric Haber, et al.
Science Translational Medicine|June 21, 2019
A Mucin 16 bispecific T cell-engaging antibody for the treatment of ovarian cancerAlison Crawford, Lauric Haber, Marcus P Kelly, et al.
Scientific Reports|July 14, 2021
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuningLauric Haber, Kara Olson, Marcus P Kelly, et al.
Science Translational Medicine|January 10, 2020
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodiesDimitris Skokos, Janelle C Waite, Lauric Haber, et al.
Pageof 1